| # | Drug | Count |
|---|---|---|
| 0 | NIRAPARIB | 498 |
| 1 | OLAPARIB | 356 |
| 2 | BEVACIZUMAB | 260 |
| 3 | CARBOPLATIN | 199 |
| 4 | RUCAPARIB | 167 |
| 5 | PACLITAXEL | 139 |
| 6 | PACLITAXEL (AIBUMIN-BOUND) | 137 |
| 7 | LETROZOLE | 97 |
| 8 | LETROZOLE TABLETS | 92 |
| 9 | GEMCITABINE HYDROCHLORIDE | 62 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NIRAPARIB | 498 | 0.0225 |
| 1 | OLAPARIB | 356 | 0.0166 |
| 2 | TOPOTECAN | 24 | 0.0039 |
| 3 | MIRVETUXIMAB SORAVTANSINE | 4 | 0.0022 |
| 4 | TRABECTEDIN | 5 | 0.0021 |
| 5 | BEVACIZUMAB | 260 | 0.0021 |
| 6 | LETROZOLE TABLETS | 92 | 0.0019 |
| 7 | DOXORUBICIN HYDROCHLORIDE | 54 | 0.0016 |
| 8 | LETROZOLE | 97 | 0.0016 |
| 9 | CARBOPLATIN | 199 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 356 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 262 |
| 2 | Platinum-based Drug [EPC] | 213 |
| 3 | Microtubule Inhibitor [EPC] | 150 |
| 4 | Aromatase Inhibitor [EPC] | 102 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 45 |
| 6 | Topoisomerase Inhibitor [EPC] | 38 |
| 7 | Alkylating Drug [EPC] | 33 |
| 8 | Loop Diuretic [EPC] | 28 |
| 9 | Provitamin D2 Compound [EPC] | 28 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 356 | 0.0166 |
| 1 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 7 | 0.0019 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 262 | 0.0014 |
| 3 | Provitamin D2 Compound [EPC] | 28 | 0.0009 |
| 4 | Microtubule Inhibitor [EPC] | 150 | 0.0009 |
| 5 | Aromatase Inhibitor [EPC] | 102 | 0.0009 |
| 6 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 7 | Platinum-based Drug [EPC] | 213 | 0.0008 |
| 8 | Melatonin Receptor Agonist [EPC] | 10 | 0.0008 |
| 9 | Topoisomerase Inhibitor [EPC] | 38 | 0.0005 |